Indication

Enteric campylobacteriosis

Enteric campylobacteriosis is an acute bacterial gastrointestinal infection primarily caused by *Campylobacter jejuni* and, less frequently, *Campylobacter coli*. Read more about Enteric campylobacteriosis

50 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Enteric campylobacteriosis therapies.

Showing 46–50 of 50 drugs

Filter & compare in the drug finder →Opens the drug finder with Enteric campylobacteriosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Enteric campylobacteriosis.

Enteric campylobacteriosis is an acute bacterial gastrointestinal infection primarily caused by *Campylobacter jejuni* and, less frequently, *Campylobacter coli*.

It predominantly targets the gastrointestinal tract—specifically the jejunum, ileum, and colon—causing mucosal inflammation, cellular damage, and diffuse exudative enteritis.

Clinically, it manifests with acute watery or bloody diarrhea, fever, nausea, and cramping abdominal pain that may mimic acute appendicitis.

While infection can occur across all age groups, young children, older adults, and immunocompromised individuals are at higher risk for severe or prolonged illness and invasive systemic disease.

Personalize your experience

Follow Enteric campylobacteriosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it